The FDA has approved yet another new version of Covid vaccines. That’s despite the fact that the vaccines don’t prevent infection, transmission, or illness. Further, some researchers say evidence indicates that the more shots a person gets, the more likely […]
The following is an excerpt from Medpage Today. The FDA has approved the first-ever vaccine for respiratory syncytial virus (RSV) the agency announced on Wednesday. Marketed under the trade name of Arexvy, the adjuvanted RSV prefusion F protein-based vaccine is specifically
FDA green lights first-ever RSV vaccine for adults 60+ Read More »
The medical industry and public health agencies are moving ahead with plans for a combination Covid-19 and flu shot. That’s despite growing questions over Covid-19 vaccine safety and effectiveness. Many scientists add that even if the Covid-19 vaccines were safe
FDA: Controversial Combo Covid-19 and flu shot to be ready in fall 2024 Read More »
The following is an excerpt from MedPage. All the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) could agree about on Wednesday in terms of a plan for Covid boosters is that they need more data. FDA staff charged VRBPAC
FDA panel mulls over Covid booster issues despite ‘insufficient data’ Read More »
